Key facts
- FULLER & THALER ASSET MANAGEMENT, INC. filed SCHEDULE 13G/A for Indivior Pharmaceuticals, Inc. Common Stock (INDV).
- Disclosed ownership: 3.7%.
- Date of event: 31 Mar 2026.
FULLER & THALER ASSET MANAGEMENT, INC. - 31 Mar 2026 SCHEDULE 13G/A Report for Indivior Pharmaceuticals, Inc. Common Stock (INDV)
- Filing manager
- FULLER & THALER ASSET MANAGEMENT, INC.
- Reporting owner
- Fuller & Thaler Asset Management, Inc.
- Beneficially owned shares
- 4,529,583 shares
- Class ownership
- 3.7%
- Symbol
- INDV
- Shares outstanding
- 121,762,997 shares
- Form type
- SCHEDULE 13G/A
- Accepted by SEC
- 13 May 2026, 16:31:16 UTC
- Event date
- 31 Mar 2026
- Previous filing
- 17 Feb 2026
- SEC filing
- View on sec.gov
Ownership signal
1 fact
Subject security
2 facts
SEC evidence
5 facts
Key filing fact
FULLER & THALER ASSET MANAGEMENT, INC. disclosed 3.7% ownership in Indivior Pharmaceuticals, Inc. Common Stock (INDV) on 31 Mar 2026.
Change
- Previous schedule filing date: 17 Feb 2026.
- Current filing was accepted on 13 May 2026, 16:31.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Fuller & Thaler Asset Management, Inc. | 3.7% | 4,529,583 | 4,351,663 | 0 | /s/ Hanna Zanoni | Chief Compliance Officer |
CIK / CUSIP context first